Stock Market News

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

wcc wcc
Apr 20, 2026 - 15:00
0 4
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.

Previous Article

Kash Patel sues The Atlantic for $250 million over alcohol abuse claims

Next Article

Sandwich chain Jersey Mike's confidentially files for IPO

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
wcc
wcc

Related Posts

Tesla Missed by 38% But Elon Musk Is Not Worried. Here’s What TSLA Investors Should Make of That.

Tesla Missed by 38% But Elon Musk Is Not Worried. He...

wcc
Jul 28, 2026
0
1
Standard Chartered: Oil Markets Must Now Price Two Middle East Chokepoints

Standard Chartered: Oil Markets Must Now Price Two M...

wcc
Jul 28, 2026
0
1
Berkshire Hathaway Holds a $28 Billion Stake in Alphabet, and Warren Buffett Says He Initiated It

Berkshire Hathaway Holds a $28 Billion Stake in Alph...

wcc
Jul 28, 2026
0
1
Warner Bros. Discovery CEO David Zaslav Sells Company Stock Worth Nearly $60 Million as the Paramount Skydance Merger Faces Delays

Warner Bros. Discovery CEO David Zaslav Sells Compan...

wcc
Jul 28, 2026
0
1
South Korea's Naver jumps 10% on Nvidia's $1 billion investment plan

South Korea's Naver jumps 10% on Nvidia's $1 billion...

wcc
Jul 28, 2026
0
1
Morgan Stanley Cuts Its Alibaba Stock Price Target

Morgan Stanley Cuts Its Alibaba Stock Price Target

wcc
Jul 28, 2026
0
1

Comments (0)

User